Skip to main content
SpringerLink
Log in

Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Daily subcutaneous doses of luteinizing hormonereleasing hormone (LHRH) analogues are a well-established therapy for gonadotropin-dependent precocious puberty. Reports on intranasally administered analogues, however, are controversial. We studied the effect of intranasal d-Ser (TBU)6-LHRH (BUS) on growth rate, skeletal maturation, and urinary gonadotropins in five girls and one boy with central precocious puberty (CPP) who had been treated for 1.4–2.3 years (mean 1.9). Because of the potential antifertility effects of LHRH analogues, testicular histology was analysed in the boy. In the five children with accelerated growth, the bone age-related velocity of heigh gain decreased from 10.58 ±2.77 to 5.82±1.8 cm/year (means±SD, P<0.01), and the ratio of change in bone age to change in chronological age fell below 1. Basal luteinizing hormone (LH), and LHRH-stimulated LH and follicle stimulating-hormone, at pubertal levels before treatment, decreased significantly in all children, normalizing in four (P<0.04). During therapy, pituitary function was best controlled by urinary LH, which correlated with clinical data. After 13 months of therapy, testicular histology showed degenerated Sertoli cells, and absence of B-and Ap-spermatogonia and of primary spermatocytes in the boy. We conclude that: (1) Efficient long-term suppression of central precocious puberty — including accelerated growth and skeletal maturation — can be maintained by intranasal dosage of BUS. (2) Urinary LH reflects pituitary function and proves to be a reliable guide to adjustment of the LHRH-analogue dose regimen. (3) Testicular atrophy after 1 year of continuous therapy with high doses of BUS raises the question of potential infertility in boys with precocious puberty treated with potent analogues of the LHRH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CPP:

central precocious puberty

LH:

luteinizing hormone

FSH:

tollicle-stimulating hormone

LHRH:

luteinizing hormone-releasing hormone

LHRHA :

LHRH analogue

BUS:

the analogue d-Ser[TBU]6-LHRH (Buserelin), HOE 766)

BA:

bone age

Δ BA/Δ CA:

ratio of change in bone age to change in chronological age

SDS:

standard deviation score

T:

urinary testosterone

E2:

urinary oestradiol

References

  1. Beitins IZ, O'Loughlin K, Ostrea T, McArthur JW (1976) Gonadotropin determinations in timed 3-hour urine collections during the menstrual cycle and LHRH testing. J Clin Endocrinol Metab 43:46–55

    Google Scholar 

  2. Beyer P, Eibs HG, Schmidt-Gollwitzer M, Weber B, Helge H (1985) Intranasal treatment of precocious puberty with a long-acting LH-RH-analogue. Pediatr Res 61:634 (abstr)

    Google Scholar 

  3. Bint Akhtar F, Wickings EJ, Nieschlag E (1984) Male fertility control with an LHRH agonist: primate studies. In: Vickery BH, Nestor JJ Jr, Hafez ESE (eds) LHRH and its analogs: contraceptive and therapeutic applications. MTP Press, Lancaster Boston The Hague Dordrecht, pp 77–90

    Google Scholar 

  4. Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, Crawford JD, Crowley WF Jr (1986) Use of a potent, long-acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr Rev 7:24–33

    Google Scholar 

  5. Brauner R, Thibaud E, Bischof P, Sizonenko PC, Rappaport R (1985) Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty. Acta Paediatr Scand 74:945–949

    Google Scholar 

  6. Clayton RN (1984) Pharmacological regulation of pituitary LHRH receptors. In: Vickery BH, Nestor JJ Jr, Hafez ESE (eds) LHRH and its analogs: contraceptive and therapeutic applications. MTP Press, Lancaster Boston The Hague Dordrecht, pp 35–46

    Google Scholar 

  7. Comite F, Cutler GB Jr, Rivier J, Vale WW, Loriaux DL, Crowley WF Jr (1981) Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. N Engl J Med 305:1546–1550

    Google Scholar 

  8. Comite F, Cassorla F, Pescovitz O, Hench K, NcNemar A, Skerda M, Valk I, Dwyer A, Cutler G, Loriaux L (1983) Normalization of growth velocity and skeletal maturation with LHRH analog therapy in girls with idiopathic precocious puberty. Pediatr Res 17:161 (abstr)

    Google Scholar 

  9. Comite F, Pescovitz OH, Rieth KG, Dwyer AJ, Hench K, McNemar A, Loriaux L, Cutler GB Jr (1984) Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty. J Clin Endocrinol Metab 59:888–892

    Google Scholar 

  10. Dacou-Voutetakis C, Sbokou D, Tolis G, Konitsiotou D, Gianoulia A (1985) Treatment of precocious puberty (PP) with a monthly injection of d-Trp6 LHRH analog (A). Pediatr Res 61: 634 (abstr)

    Google Scholar 

  11. Donaldson MDC, Stanhope R, Lee TJ, Price DA, Brook CGD, Savage DCL (1984) Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue. Clin Endocrinol 21:499–503

    Google Scholar 

  12. Girard J, Baumann JB, Ruch W (1980) Diagnostic possibilities in delayed puberty. In: Cacciari E, Prader A (eds) Pathophysiology of puberty. Academic Press, London New York, pp 223–237

    Google Scholar 

  13. Hadziselimovic F (1977) Cryptorchidism. Springer, Berlin Heidelberg New York

    Google Scholar 

  14. Hadziselimovic F, Senn E, Bandhauer K (1988) Effect of gonadotropin releasing hormone agonist treatment on human testis. J Urol 138:1048–1050

    Google Scholar 

  15. Hansen JW, Ross GT (1975) A new method simplifying collection of serial speciments for gonadotropin determinations. J Clin Endocrinol Metab 41:241–244

    Google Scholar 

  16. Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M (1985) Somatomedin-C in normal puberty and true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 61:152–159

    Google Scholar 

  17. Jones PBC, Hsueh AJW (1984) Direct antigonadal actions of LHRH. In: Vickery BH, Nestor JJ Jr, Hafez ESE (eds) LHRH and its analogs: contraceptive and therapeutic applications. MTP Press, Lancaster Boston The Hague Dordrecht, pp 163–179

    Google Scholar 

  18. Kauli R, Kalter-Leibovici O, Schally AV, Comaru-Schally AM, Szoke B, Laron Z (1985) Long term therapy of precocious puberty with the suneractive LHRH-analogue d-Trp6-LH-RH. Pediatr Res 61:635 (abstr)

    Google Scholar 

  19. Kulin HE, Santner SJ (1977) Timed urinary gonadotropin measurements in normal infants, children and adults, and in patients with disorders of sexual maturation. J Pediatr 90:760–765

    Google Scholar 

  20. Kulin HE, Bell PM, Santen RJ, Ferber AJ (1975) Integration of pulsatile gonadotropin secretion by time urinary measurements: an accurate and sensitive 3-hour test. J Clin Endocrinol Metab 40:783–789

    Google Scholar 

  21. Lahlou N, Chaussain JL, Piot AM, Roger M, Toublanc JE, Schally AV (1986) Differential effect of d-Trp6-LHRH in microcapsules (LRH-M) upon LH and LHalpha release during long term treatment of precocious puberty (PP). Proceedings of the 25th annual meeting of the European Society for Paediatric Endocrinology. Pediatr Res 20:1179 (abstr)

    Google Scholar 

  22. Laron Z, Rumney G, Rat L, Naji N (1963) Effect of 17alpha-hydroxy-6alpha methylprogesterone acetate (Depo-Provera) on urinary gonadotrophins and oestrogens in man. Acta Endocrinol 44:75–80

    Google Scholar 

  23. Leither C, Happ J (1986) Treatment of idiopathic precocious puberty with a GnRH superagonist using different modes of administration. Acta Endocrinol [Suppl 274] 111:81

    Google Scholar 

  24. Lemli L, Aron M, Smith DW (1964) The actions of Depo-Provera in 3 girls with idiopathic isosexual precocity: decrease in oestrogen effect without urinary gonadotropin reduction. J Pediatr 65:888–894

    Google Scholar 

  25. Lin T-H, LePage ME, Henzl M, Kirkland JL (1985) Intranasal LHRH analogue treatment of idiopathic central precocious puberty in girls. Pediatr Res 16:633 (abstr)

    Google Scholar 

  26. Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D (1981) Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med 305:663–667

    Google Scholar 

  27. Luder AS, Holland FJ, Costigan DC, Jenner MR, Wielgosz G, Fazekas ATA (1984) Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 58:966–972

    Google Scholar 

  28. Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF Jr, Crowley WF Jr (1983) Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone: effects on somatic growth and skeletal maturation. N Engl J Med 309:1286–1290

    Google Scholar 

  29. Mohnfeld G, Mauss J, Börsch G (1974) Synthetic LH-RH stimulation monitored by immunochemical assay for urinary FSH and LH. Horm Metab Res 6:336–337

    Google Scholar 

  30. Morel Y, Betuel JP, Chatelain P, Perez J, Sempé M, Roger M, David M (1986) Long term follow-up of LHRH-A treatment of precocious puberty by urinary gonadotropins (UG): escape of FSH desensitization in girls. Proceedings of the 25th annual meeting of the European Society for Paediatric Endocrinology. Pediatr Res 20:1185 (abstr)

    Google Scholar 

  31. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL, Cutler GB Jr (1984) True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab 58:857–861

    Google Scholar 

  32. Pescovitz OH, Rosenfeld RG, Hintz RL, Barnes K, Hench K, Comite F, Loriaux DL, Cutler GB Jr (1985) Somatomedin-C in accelerated growth of children with precocious puberty. J Pediatr 107:20–25

    Google Scholar 

  33. Pescovitz OH, Comite F, Hench K, Barnes K, McNemar A, Foster C, Kenigsberg D, Loriaux L, Cutler GB Jr (1986) The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone-releasing hormone analogue therapy. J Pediatr 108:47–54

    Google Scholar 

  34. Stanhope R, Adams J, Brook CGD (1985) The treatment of central precocious puberty using an intranasal LHRH analogue (Buserelin). Clin Endocrinol 22:795–806

    Google Scholar 

  35. Tanner JM (1962) Growth and adolescence. Blackwell, Oxford

    Google Scholar 

  36. Tanner JM, Whitehouse RH, Marshall WA (1975) Assessment of skeletal maturity and prediction of adult height (TW2 method). Academic Press, London New York San Francisco

    Google Scholar 

  37. Vickery BH, McRae GI (1984) Male contraceptive potential of nafarelin acetate assessed in the dog. In: Vickery BH, Nestor JJ Jr, Hafez ESE (eds) LHRH and its analogs: contraceptive and therapeutic applications. MTP Press, Lancaster Boston The Hague Dordrecht, pp 61–75

    Google Scholar 

  38. Ward PS, Ward I, McNinch AW, Savage DCL (1985) Reversible inhibition of central precocious puberty with a long-acting GnRH analogue. Arch Dis Child 60:872–874

    Google Scholar 

  39. Werder EA, Illig R, Zachmann M, Torresani T, Prader A (1986) Treatment of precocious puberty in girls with intranasal LHRH agonist (Buserelin). Proceedings of the 25th annual meeting of the European Society for Paediatric Endocrinology. Pediatr Res 20: 1185 (abstr)

    Google Scholar 

  40. Wielgosz GJ, Jenner MR, Fazekas AT (1984) Effects of eighteen months treatment of a three-year-old boy with central precocious puberty (CPP) with LHRH analogue d-SER (TBU)6-LHRH 1-9E10 (HOE 766). J Steroid Biochem 20:1411 (abstr)

    Google Scholar 

  41. Zachmann M, Prader A, Kind HP, Haflinger H, Budliger H (1974) Testicular volume during adolescence. Helv Paediatr Acta 29:61–72

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wildermeth Children's Hospital, CH-2503, Biel, Switzerland

    J. -L. Rime, A. Blumberg & R. P. Zurbrügg

  2. University Children's Hospital, Römergasse 8, CH-4000, Basel, Switzerland

    U. Zumsteg, F. Hadziselimovic & J. Girard

Authors
  1. J. -L. Rime
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Zumsteg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Blumberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Hadziselimovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Girard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. P. Zurbrügg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rime, J.L., Zumsteg, U., Blumberg, A. et al. Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins. Eur J Pediatr 147, 263–269 (1988). https://doi.org/10.1007/BF00442692

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442692

Key words

Search

Navigation